These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23847367)

  • 21. Identification of a novel CSF3R-SPTAN1 fusion gene in an atypical chronic myeloid leukemia patient with t(1;9)(p34;q34) by RNA-Seq.
    Sheng G; Zhang J; Zeng Z; Pan J; Wang Q; Wen L; Xu Y; Wu D; Chen S
    Cancer Genet; 2017 Oct; 216-217():16-19. PubMed ID: 29025591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic neutrophilic leukemia: novel mutations and their impact on clinical practice.
    Tefferi A; Elliott M; Pardanani A
    Curr Opin Hematol; 2015 Mar; 22(2):171-6. PubMed ID: 25575036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A CSF3R T618I Mutation in a Patient with Chronic Neutrophilic Leukemia and Severe Bleeding Complications.
    Mitsumori T; Komatsu N; Kirito K
    Intern Med; 2016; 55(4):405-7. PubMed ID: 26875968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.
    Pardanani A; Lasho TL; Laborde RR; Elliott M; Hanson CA; Knudson RA; Ketterling RP; Maxson JE; Tyner JW; Tefferi A
    Leukemia; 2013 Sep; 27(9):1870-3. PubMed ID: 23604229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical CML with mutated SRSF2, ASXL1, CSF3R, and MPL.
    Tran A; Wong M
    Blood; 2021 Dec; 138(26):2890. PubMed ID: 34967865
    [No Abstract]   [Full Text] [Related]  

  • 26. CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
    Qian Y; Chen Y; Li X
    Ann Hematol; 2021 Jun; 100(6):1459-1461. PubMed ID: 33822276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inherited transmission of the CSF3R T618I mutational hotspot in familial chronic neutrophilic leukemia.
    Duployez N; Willekens C; Plo I; Marceau-Renaut A; de Botton S; Fenwarth L; Boyer T; Huet G; Nibourel O; Rose C; Nelken B; Quesnel B; Preudhomme C
    Blood; 2019 Dec; 134(26):2414-2416. PubMed ID: 31697825
    [No Abstract]   [Full Text] [Related]  

  • 28. ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia.
    Elliott MA; Pardanani A; Hanson CA; Lasho TL; Finke CM; Belachew AA; Tefferi A
    Am J Hematol; 2015 Jul; 90(7):653-6. PubMed ID: 25850813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review.
    Wu XB; Wu WW; Zhou Y; Wang X; Li J; Yu Y
    BMC Cancer; 2018 Mar; 18(1):343. PubMed ID: 29587671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexistence of multiple myeloma and a CSF3R-mutated myeloid neoplasm.
    Stewart W; Hinton R; Bain BJ
    Am J Hematol; 2021 Nov; 96(11):1539-1540. PubMed ID: 34028856
    [No Abstract]   [Full Text] [Related]  

  • 31. Atypical Chronic Myeloid Leukemia in Two Pediatric Patients.
    Freedman JL; Desai AV; Bailey LC; Aplenc R; Burnworth B; Zehentner BK; Teachey DT; Wertheim G
    Pediatr Blood Cancer; 2016 Jan; 63(1):156-9. PubMed ID: 26274939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
    Dao KT; Gotlib J; Deininger MMN; Oh ST; Cortes JE; Collins RH; Winton EF; Parker DR; Lee H; Reister A; Schultz ; Savage S; Stevens ; Brockett C; Subbiah N; Press RD; Raess PW; Cascio M; Dunlap J; Chen Y; Degnin C; Maxson JE; Tognon CE; Macey T; Druker BJ; Tyner JW
    J Clin Oncol; 2020 Apr; 38(10):1006-1018. PubMed ID: 31880950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic neutrophilic leukemia (CNL) with karyotypic abnormalities associated with plasma cell dyscrasia: a case report.
    Masini L; Salvarani C; Macchioni P; Baldi G; Rossi F; Croci G; Prandi S; Davoli C; Portioli I; Gobbi F
    Haematologica; 1992; 77(3):277-9. PubMed ID: 1427435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current strategies in the diagnosis and management of chronic neutrophilic leukemia.
    Otgonbat A; Zhao M
    Chin Med J (Engl); 2014; 127(24):4258-62. PubMed ID: 25533830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of gene mutation characteristics in patients with chronic neutrophilic leukaemia.
    Yin B; Chen X; Gao F; Li J; Wang HW
    Hematology; 2019 Dec; 24(1):538-543. PubMed ID: 31315541
    [No Abstract]   [Full Text] [Related]  

  • 36. CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia.
    Cui Y; Li B; Gale RP; Jiang Q; Xu Z; Qin T; Zhang P; Zhang Y; Xiao Z
    J Hematol Oncol; 2014 Oct; 7():77. PubMed ID: 25316523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management.
    Szuber N; Elliott M; Tefferi A
    Am J Hematol; 2020 Feb; 95(2):212-224. PubMed ID: 31769070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CSF3R T618I mutation as a disease-specific marker of atypical CML post allo-SCT.
    Langabeer SE; McCarron SL; Haslam K; O'Donovan MT; Conneally E
    Bone Marrow Transplant; 2014 Jun; 49(6):843-4. PubMed ID: 24614839
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chronic neutrophilic leukemia with CSF3R mutation and concurrent multiple myeloma: one case report].
    He M; Zhao XC; Bai H
    Zhonghua Xue Ye Xue Za Zhi; 2019 Dec; 40(12):1052. PubMed ID: 32023742
    [No Abstract]   [Full Text] [Related]  

  • 40. Janus kinases promote cell-surface expression and provoke autonomous signalling from routing-defective G-CSF receptors.
    Meenhuis A; Irandoust M; Wölfler A; Roovers O; Valkhof M; Touw IP
    Biochem J; 2009 Feb; 417(3):737-46. PubMed ID: 18922133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.